Patients Needed
for National Institutes of Health (NIH) Study

Trial to Assess Chelation Therapy (TACT)

The NIH-sponsored Trial to Assess Chelation Therapy (TACT) is a research study, which will test the effectiveness of chelation therapy for the treatment of coronary heart disease (CHD), for patients who have survived a heart attack.

For more information about coronary artery disease, EDTA chelation therapy to treat coronary artery disease, the controversy about this treatment and the clinical study, visit the website of the National Center for Complementary and Alternative Medicine. 

If you participate in this study, you will receive 28 months of treatment, and be asked to participate in up to 32 months of follow-up.  You will not be charged for participating in this exciting study and will receive the study drug and vitamin and mineral supplements.

To be eligible to participate in TACT you must have had a heart attack, be at least 50 years old, not be a recent smoker or have had chelation therapy for at least 5 years.

To find out more, please contact:

Sally Minniefield, RN, PA-C
Clinical Coordinator of the TACT Trial
at the
Schachter Center for Complementary Medicine
845-368-4700